Centessa Pharmaceuticals (CNTA) Stock Chart & Stock Price History → Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad) Free CNTA Stock Alerts $8.79 -0.25 (-2.77%) (As of 05/15/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Centessa Pharmaceuticals Stock Price Performance5 Day Performance-2.01%1 Month Performance-18.46%3 Month Performance-18.84%6 Month Performance+21.91%Year-To-Date Performance+10.43%1 Year Performance+89.44% Receive CNTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Centessa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Chaikin AnalyticsThis Wall Street stock prediction just went viralPeople around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.Watch just the first 5 minutes of his new prediction CNTA Stock Chart for Thursday, May, 16, 2024 CNTA Chart by TradingView Centessa Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/14/2024$8.83$9.04+2.38%$9.70$8.81101,785 shs$910.69 million05/13/2024$8.97$8.83-1.56%$9.33$8.74147,249 shs$889.53 million05/10/2024$9.55$8.97-6.07%$9.68$8.8368,436 shs$903.64 million05/09/2024$9.48$9.55+0.74%$9.66$9.3166,810 shs$962.07 million05/08/2024$9.67$9.48-1.96%$9.70$9.3274,604 shs$955.02 million05/07/2024$9.25$9.67+4.54%$9.71$8.93161,793 shs$974.16 million Get the Latest News and Ratings for CNTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Centessa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/06/2024$9.47$9.25-2.32%$9.50$9.2474,239 shs$927.83 million05/03/2024$9.55$9.47-0.84%$9.97$9.2975,657 shs$949.94 million05/02/2024$9.48$9.55+0.74%$9.62$9.19299,775 shs$957.96 million05/01/2024$9.16$9.48+3.49%$9.64$8.98233,751 shs$950.90 million04/30/2024$9.29$9.16-1.40%$9.59$9.13140,804 shs$918.84 million04/29/2024$8.92$9.29+4.15%$9.34$8.87152,754 shs$931.88 million04/26/2024$8.93$8.92-0.11%$9.11$8.70254,924 shs$894.77 million04/25/2024$9.46$8.93-5.60%$9.39$8.90286,486 shs$895.77 million04/24/2024$9.40$9.46+0.64%$9.53$8.682.25 million shs$948.93 million04/23/2024$10.00$9.40-6.00%$10.17$9.37199,967 shs$942.91 million04/22/2024$10.57$10.00-5.39%$10.90$9.70210,758 shs$1.00 billion04/19/2024$10.53$10.57+0.38%$10.66$10.26150,106 shs$1.06 billion04/18/2024$10.78$10.53-2.32%$10.84$10.37109,521 shs$1.06 billion04/17/2024$11.03$10.78-2.27%$11.25$10.73120,741 shs$1.08 billion04/16/2024$10.78$11.03+2.32%$11.32$10.53172,743 shs$1.11 billion04/15/2024$11.32$10.78-4.77%$11.38$10.7371,958 shs$1.08 billion04/12/2024$11.87$11.32-4.63%$11.97$10.94186,748 shs$1.11 billion04/11/2024$11.15$11.87+6.46%$12.25$10.93153,539 shs$1.16 billion04/10/2024$11.31$11.15-1.37%$11.23$10.8489,460 shs$1.09 billion04/09/2024$10.75$11.31+5.16%$11.33$10.80114,375 shs$1.10 billion04/08/2024$10.75$10.75$10.85$10.2069,337 shs$1.05 billion04/05/2024$10.37$10.75+3.66%$10.76$10.06133,482 shs$1.05 billion04/04/2024$10.82$10.37-4.16%$11.01$10.05102,434 shs$1.01 billion04/03/2024$11.33$10.82-4.50%$11.29$10.58175,279 shs$1.06 billion04/02/2024$11.08$11.33+2.26%$11.37$10.59170,191 shs$1.11 billion04/01/2024$11.30$11.08-1.95%$11.48$10.56245,371 shs$1.08 billion03/29/2024$11.30$11.30$11.47$10.82172,360 shs$1.10 billion03/28/2024$11.10$11.30+1.80%$11.47$10.82172,356 shs$1.10 billion03/27/2024$10.76$11.10+3.16%$11.23$10.3968,643 shs$1.08 billion03/26/2024$11.51$10.76-6.52%$11.80$10.71105,064 shs$1.05 billion03/25/2024$12.20$11.51-5.66%$12.44$11.06447,533 shs$1.12 billion03/22/2024$12.08$12.20+0.99%$12.40$11.89161,278 shs$1.19 billion03/21/2024$11.84$12.08+2.03%$12.41$11.85258,685 shs$1.18 billion03/20/2024$11.17$11.84+6.00%$11.85$10.89553,402 shs$1.16 billionThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)Nanoviricides Technology Will Transform The Way Viruses & Their Variants Are Treated Worldwide And This Company Is At The Forefront!See how with its ongoing expansion and development03/19/2024$10.62$11.17+5.18%$11.23$9.88324,674 shs$1.09 billion03/18/2024$10.75$10.62-1.21%$10.93$10.27269,541 shs$1.04 billion03/15/2024$10.47$10.75+2.67%$10.94$10.30216,667 shs$1.05 billion03/14/2024$10.85$10.47-3.50%$10.89$10.43167,992 shs$1.02 billion03/13/2024$10.86$10.85-0.09%$11.10$10.8075,254 shs$1.06 billion03/12/2024$9.75$10.86+11.38%$10.99$9.79195,281 shs$1.06 billion03/11/2024$11.03$9.75-11.60%$10.93$9.71250,009 shs$951.89 million03/08/2024$11.06$11.03-0.27%$11.31$10.9685,623 shs$1.08 billion03/07/2024$11.03$11.06+0.27%$11.64$10.80204,973 shs$1.08 billion03/06/2024$10.89$11.03+1.29%$11.15$10.57142,926 shs$1.08 billion03/05/2024$11.17$10.89-2.51%$11.19$10.54154,084 shs$1.06 billion03/04/2024$10.87$11.17+2.76%$11.20$10.75215,000 shs$1.09 billion03/01/2024$10.51$10.87+3.43%$11.00$10.28260,983 shs$1.06 billion02/29/2024$10.44$10.51+0.67%$10.74$10.1487,093 shs$1.03 billion02/28/2024$11.36$10.44-8.10%$11.49$10.30114,801 shs$1.02 billion02/27/2024$11.29$11.36+0.62%$11.66$11.00187,216 shs$1.11 billion02/26/2024$11.01$11.29+2.54%$11.80$11.00282,055 shs$1.10 billion02/23/2024$10.75$11.01+2.42%$11.18$10.41327,836 shs$1.07 billion02/22/2024$10.40$10.75+3.37%$11.32$10.41180,924 shs$1.05 billion02/21/2024$10.66$10.40-2.44%$10.50$10.00979,022 shs$1.02 billion02/20/2024$11.75$10.66-9.28%$11.95$10.55189,475 shs$1.04 billion02/19/2024$11.75$11.75$11.86$10.68669,900 shs$1.15 billion02/16/2024$10.83$11.75+8.49%$11.86$10.68669,989 shs$1.15 billion02/15/2024$10.18$10.83+6.39%$10.84$10.18851,893 shs$1.06 billion02/14/2024$9.50$10.18+7.16%$10.20$9.531.46 million shs$993.87 million Related Companies: LQDA Stock Price Chart INVA Stock Price Chart MGNX Stock Price Chart SAVA Stock Price Chart TYRA Stock Price Chart IMNM Stock Price Chart OCUL Stock Price Chart ABVX Stock Price Chart SPRY Stock Price Chart ARQT Stock Price Chart Receive CNTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Centessa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CNTA) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportPharma Giant Makes Deal with a "Drug Smuggler"Behind the MarketsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centessa Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.